Nemera's Safe'n'Sound responds to pharma and user needs

Providing premium safety, Safe'n'Sound® is a Nemera's solution to avoid needlestick injuries offering a passive safety device platform for prefilled syringes.

Nemera's Safe'n'Sound has been especially designed for compatibility with prefilled ISO standard glass syringes and PLAJEX plastic syringes, fitting 1ml and 2.25ml long staked syringes with a needle length of up to half an inch.

The round shape offers an increased labelling surface and the large thumb pad grants ease of use, which is ideal for both naive users as well as healthcare professionals to aid in protection against accidental needle injuries.

It is robust against shocks and vibrations yet easy to actuate with one hand. Suitable for low fill volumes and higher viscosity formulations Nemera's Safe'n'Sound is compatible with manual and fully automated assembly lines.

 

 

See also

Nemera's RetroNose enhances therapeutic efficacy of nasal treatments

The number of applications through the nasal route is expanding, either for local treatments (e.g. chronic rhinosinusitis) or for systemic treatments (e.g. migraine, etc.). The clinical efficacy of a nasal treatment depends on how it is deposited in the nose, because the pharmaceutical target (local, systemic, brain) is directly related to a specific nasal anatomical site. That’s why Nemera has collaborated with CEPR to develop a different and portable delivery technology called RetroNose for a better drug deposition in the distal region of the nose, without lung deposition.

e-Novelia wins the ‘Excellence in Pharma: Drug Delivery Devices’ award at CPhI Worldwide 2018

On October 9th, during the CPhI Pharma Awards Gala, e-Novelia®, Nemera’s electronic add-on for ophthalmic droppers, was celebrated as the best-in-class innovation displayed at the show for “Excellence in Pharma: Drug Delivery Devices”. e-Novelia®, Nemera’s smart ophthalmic add-on, has been designed to make patients’ life easier, by offering increased comfort and optimized adherence to their treatments.

Safelia 1ml and 2.25ml autoinjectors designed to be patient and syringe friendly

Nemera’s new generation 2-step autoinjector platforms are suitable for fluid to highly viscous injections. Safelia® has been designed to ease patient self-injection experience and to deliver even the most challenging drugs (viscous formulations up to several Centipoise, sustain released, concentrated, fragile and shear sensitive formulations, either in subcutaneous or intramuscular layers, on two platforms: up to 1ml or up to 2.25ml delivery).

  • Jo Webb
  • Product Info
  • English
  • Created 01 May 2018
  • Modified 12 Jul 2018
  • Hits 1394